TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23271206

Group type: EXPERIMENTAL
Intervention: Two-legged hopping (TLH)
Number of subjects: 17

Group type: COMPARATOR
Intervention: One-legged hopping (OLH)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Both OLH and TLH
Number of subjects: 17
Study: 21586501

Group type: EXPERIMENTAL
Intervention: Social Effectiveness Therapy for Children (SET‐C)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pill placebo
Number of subjects: 0
Study: 17950038

Group type: EXPERIMENTAL
Intervention: Rofecoxib (25 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 16933524

Group type: EXPERIMENTAL
Intervention: Nurse-based telephone protocol
Number of subjects: 212

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 212
Study: 12439628

Group type: EXPERIMENTAL
Intervention: Clomipramine
Number of subjects: 104

Group type: COMPARATOR
Intervention: Desipramine
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Baseline prolactin (BLP)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: TRP/LNAA ratio
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Low TRP/LNAA values
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: High TRP/LNAA values
Number of subjects: 104
Study: 11071049

Group type: EXPERIMENTAL
Intervention: Salbutamol (Sal, 6 mg)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo (Pla)
Number of subjects: 9
Study: 8694013

Group type: EXPERIMENTAL
Intervention: Fortified breast milk with multinutrient fortifier (mean duration 39 days)
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: Fortified breast milk
Number of subjects: 275

Group type: COMPARATOR
Intervention: Control supplement containing phosphate and vitamins
Number of subjects: 275
Study: 1304482

Group type: EXPERIMENTAL
Intervention: Single carboplatin (cp) at the dose of 260‐410 mg/m2
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Combination chemotherapy of carboplatin (cp) at a dose of 180‐350 mg/m2 plus adriamycin and cyclophosphamide
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Single carboplatin (cp)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Combination chemotherapy of carboplatin (cp) plus adriamycin and cyclophosphamide
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Carboplatin (cp)
Number of subjects: 53
Study: 3534333

Group type: EXPERIMENTAL
Intervention: Lovastatin (mevinolin) 40 mg twice a day
Number of subjects: 101

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101
Study: 31189408

Group type: EXPERIMENTAL
Intervention: Supernatural afterlife-confirmed prime
Number of subjects: 742

Group type: EXPERIMENTAL
Intervention: Natural (medical indefinite life extension; MILE) immortality prime
Number of subjects: 742

Group type: COMPARATOR
Intervention: Mortality Salience (MS) prime
Number of subjects: 742
Study: 30172864

Group type: EXPERIMENTAL
Intervention: Hyoscine Butylbromide (HB) administered once DR occurs (Group 1)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Hyoscine Butylbromide (HB) given prophylactically (Group 2)
Number of subjects: 132
Study: 26614176

Group type: EXPERIMENTAL
Intervention: IVIG
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Pentaglobin(®)
Number of subjects: 59
Study: 25348244

Group type: EXPERIMENTAL
Intervention: APAP treatment
Number of subjects: 156

Group type: COMPARATOR
Intervention: CPAP treatment
Number of subjects: 156
Study: 22048129

Group type: EXPERIMENTAL
Intervention: 7 mg transdermal nicotine
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: 21 mg transdermal nicotine
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 29
Study: 20346217

Group type: EXPERIMENTAL
Intervention: Combined temperature- and power-controlled RFA
Number of subjects: 55

Group type: COMPARATOR
Intervention: Power-controlled RFA
Number of subjects: 55
Study: 18615988

Group type: EXPERIMENTAL
Intervention: Stepwise excavation over 2 visits
Number of subjects: 0

Group type: COMPARATOR
Intervention: Complete excavation of deep caries
Number of subjects: 0
Study: 19664296

Group type: EXPERIMENTAL
Intervention: Trehalose (75 g carbohydrate equivalents)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Glucose (75 g carbohydrate equivalents)
Number of subjects: 10
Study: 15020035

Group type: EXPERIMENTAL
Intervention: Experimental agent (exact agent not specified)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 0
Study: 11686541

Group type: EXPERIMENTAL
Intervention: Aldosterone (0.5 mg) during normoxia (FiO2=0.21)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo during normoxia (FiO2=0.21)
Number of subjects: 9
Study: 9457566

Group type: EXPERIMENTAL
Intervention: Trapeziectomy alone
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Trapeziectomy with tendon interposition
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Trapeziectomy with ligament reconstruction
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 76
Study: 8186174

Group type: EXPERIMENTAL
Intervention: Ondansetron plus dexamethasone
Number of subjects: 215

Group type: COMPARATOR
Intervention: Ondansetron plus placebo
Number of subjects: 215
Study: 3285877

Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 434

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 434
Study: 30817416

Group type: EXPERIMENTAL
Intervention: Telephone nursing
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Calmness of the nurse during the call
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Clarity of advice given
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Competence of the nurse
Number of subjects: 500
Study: 31496531

Group type: EXPERIMENTAL
Intervention: Partial rebreathing mask (PRM)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Hudson's mask
Number of subjects: 88
Study: 28800842

Group type: EXPERIMENTAL
Intervention: 3D prediction technique
Number of subjects: 57

Group type: COMPARATOR
Intervention: 2D prediction technique
Number of subjects: 57
Study: 26311179

Group type: EXPERIMENTAL
Intervention: Gradual protocol
Number of subjects: 13

Group type: COMPARATOR
Intervention: Abrupt protocol
Number of subjects: 13
Study: 24280575

Group type: EXPERIMENTAL
Intervention: Electroacupuncture
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo control acupuncture
Number of subjects: 60
Study: 20665468

Group type: EXPERIMENTAL
Intervention: Stroke specific Geriatric Depression Scale (SS‐GDS)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: SS‐GDS
Number of subjects: 91
Study: 20186638

Group type: EXPERIMENTAL
Intervention: Intervention based on self-determination theory
Number of subjects: 215

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 215
Study: 17663307

Group type: EXPERIMENTAL
Intervention: Arginine vasopressin receptor antagonists
Number of subjects: 0
Study: 15313942

Group type: EXPERIMENTAL
Intervention: Left Ventricular Assist Device (LVAD)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Optimal Medical Management (OMM)
Number of subjects: 91
Study: 11706714

Group type: EXPERIMENTAL
Intervention: Phlogenzym (3 times 3 tablets for the first three days, then 3 times 2 tablets)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard antioedematous drugs based on aescin (control group)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Phlogenzym
Number of subjects: 60
Study: 9536580

Group type: EXPERIMENTAL
Intervention: Ames reagent strip
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Boehringer reagent strip
Number of subjects: 100
Study: 8201151

Group type: EXPERIMENTAL
Intervention: Low-dose aspirin therapy
Number of subjects: 400

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 400
Study: 3295590

Group type: EXPERIMENTAL
Intervention: Progabide (PGB)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 28967441

Group type: EXPERIMENTAL
Intervention: 20h of visual processing training plus cognitive remediation
Number of subjects: 20

Group type: COMPARATOR
Intervention: 20h of computer‐assisted cognitive remediation alone
Number of subjects: 20
Study: 26892534

Group type: EXPERIMENTAL
Intervention: Single Chamber (SC) settings
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dual Chamber (DC) settings
Number of subjects: 0
Study: 24295879

Group type: EXPERIMENTAL
Intervention: Multifaceted, practice-directed intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard dissemination
Number of subjects: 0
Study: 23285646

Group type: EXPERIMENTAL
Intervention: Block-like sutures and radiofrequency coagulation
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Ultrasonographic, jet-like dissection, or clamp crushing methods
Number of subjects: 90
Study: 20346025

Group type: EXPERIMENTAL
Intervention: 308-nm excimer laser
Number of subjects: 20

Group type: COMPARATOR
Intervention: 308-nm excimer lamp
Number of subjects: 20
Study: 18538648

Group type: EXPERIMENTAL
Intervention: Low-intensity pulsed ultrasound (LIPUS)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control (untreated)
Number of subjects: 13
Study: 15944532

Group type: EXPERIMENTAL
Intervention: Adenosine myocardial perfusion imaging (MPI)
Number of subjects: 126
Study: 12528584

Group type: EXPERIMENTAL
Intervention: Nurse-led clinic in schools
Number of subjects: 0

Group type: COMPARATOR
Intervention: General practice care
Number of subjects: 0
Study: 9706373

Group type: EXPERIMENTAL
Intervention: New slow-release tablet formulation (Pindac)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Standard slow-release capsule formulation
Number of subjects: 18
Study: 7644775

Group type: EXPERIMENTAL
Intervention: Salmeterol (100 micrograms b.d.)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 2766522

Group type: EXPERIMENTAL
Intervention: St. Jude Medical prosthetic heart valves
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Medtronic Hall prosthetic heart valves
Number of subjects: 90

Group type: COMPARATOR
Intervention: St. Jude Medical aortic prostheses
Number of subjects: 90

Group type: COMPARATOR
Intervention: Medtronic Hall aortic prostheses
Number of subjects: 90

Group type: COMPARATOR
Intervention: St. Jude Medical mitral prostheses
Number of subjects: 90

Group type: COMPARATOR
Intervention: Medtronic Hall mitral prostheses
Number of subjects: 90
Study: 238412

Group type: EXPERIMENTAL
Intervention: AH 8165
Number of subjects: 0
Study: 29488461

Group type: EXPERIMENTAL
Intervention: Household WASH package (chlorine, soap, water storage container, and promotion on its use)
Number of subjects: 1603

Group type: COMPARATOR
Intervention: Control (OTP only)
Number of subjects: 1603
Study: 27627817

Group type: EXPERIMENTAL
Intervention: 200 mg aspirin before surgery and 100 mg daily for up to 30 days after surgery
Number of subjects: 10010

Group type: COMPARATOR
Intervention: Placebo before surgery and placebo daily for up to 30 days after surgery
Number of subjects: 10010

Group type: EXPERIMENTAL
Intervention: Aspirin (pooled analysis)
Number of subjects: 10010

Group type: COMPARATOR
Intervention: Placebo (pooled analysis)
Number of subjects: 10010
Study: 24478190

Group type: EXPERIMENTAL
Intervention: Iodixanol 270 mg iodine pro ml
Number of subjects: 148

Group type: COMPARATOR
Intervention: Ioversol 320 mg iodine pro ml
Number of subjects: 148
Study: 22095021

Group type: EXPERIMENTAL
Intervention: Multimodal intervention
Number of subjects: 447

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 447
Study: 20401355

Group type: EXPERIMENTAL
Intervention: Glutamate (1.0 mol/L) injection
Number of subjects: 52

Group type: COMPARATOR
Intervention: Co-injection of NMDA antagonist ketamine (10 mmol/L)
Number of subjects: 52
Study: 18703787

Group type: EXPERIMENTAL
Intervention: Withdrawal of life-sustaining interventions taking more than 1 day
Number of subjects: 584

Group type: EXPERIMENTAL
Intervention: Extubation before death
Number of subjects: 584
Study: 15903363

Group type: EXPERIMENTAL
Intervention: Open‐stance cycling protocol (OSCP)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Traditional cycling foot position (TCFP)
Number of subjects: 40
Study: 12621274

Group type: EXPERIMENTAL
Intervention: End-tidal CO2 monitoring
Number of subjects: 40
Study: 11711256

Group type: EXPERIMENTAL
Intervention: Azithromycin oral suspension, 10 mg/kg once daily for 3 days
Number of subjects: 2425
Study: 9174835

Group type: EXPERIMENTAL
Intervention: Glutathione (GSH) levels in plasma
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Glutathione disulfide (GSSG) levels in plasma
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: GSH/GSSG ratio
Number of subjects: 0
Study: 1634055

Group type: EXPERIMENTAL
Intervention: MRI technique for measuring gastric emptying using a liquid meal containing Gadolinium tetraazacyclododecane tetraacetic acid as a marker.
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: MRI technique for measuring total gastric volumes and gastric secretory rates.
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: MRI method for reflecting gastric emptying disorders in patients.
Number of subjects: 10
Study: 3980239

Group type: EXPERIMENTAL
Intervention: Educational program for family members including counseling and a booklet on supporting medication compliance, appointment keeping, diet, and weight control.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 0
Study: 30880271

Group type: EXPERIMENTAL
Intervention: First arm: 59.5 Gy to the gross tumor volume and 47.6 Gy to the remaining larynx, delivered in 17 fractions.
Number of subjects: 13

Group type: COMPARATOR
Intervention: Second arm: 55 Gy to the gross tumor volume and 40.7 Gy to the remaining larynx, delivered in 11 fractions.
Number of subjects: 13
Study: 28834086

Group type: EXPERIMENTAL
Intervention: Elevated IL-6 (third tertile vs first tertile)
Number of subjects: 1485

Group type: EXPERIMENTAL
Intervention: Combined elevated levels of CRP and IL-6 (both markers ≥75th percentile vs <75th percentile)
Number of subjects: 1485

Group type: EXPERIMENTAL
Intervention: Combined elevated levels of CRP and fibrinogen (both markers ≥75th percentile vs <75th percentile)
Number of subjects: 1485
Study: 27958622

Group type: EXPERIMENTAL
Intervention: 1 g of intravenous ampicillin every 6 hours
Number of subjects: 148

Group type: COMPARATOR
Intervention: 2 g of intravenous ampicillin every 6 hours
Number of subjects: 148
Study: 25219200

Group type: EXPERIMENTAL
Intervention: Rush immunotherapy (RIT)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Conventional immunotherapy
Number of subjects: 87
Study: 22185492

Group type: EXPERIMENTAL
Intervention: Distractor condition with orientation changes preceding the cue
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control condition with coherent motion of the bars
Number of subjects: 13
Study: 20207497

Group type: COMPARATOR
Intervention: Conventional radiation (70.2 GyE)
Number of subjects: 64

Group type: COMPARATOR
Intervention: High-dose radiation (79.2 GyE)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: DVH parameters (V60 > 54%, V70 > 44%, V75 > 39%)
Number of subjects: 64
Study: 17261244

Group type: EXPERIMENTAL
Intervention: Combination of three drugs from two different classes (2 nucleosides or nucleotide analogs (NRTI) plus 1 non‐nucleoside (NNRTI) or 1 boosted protease inhibitor (PI/r))
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Initiation of ART in patients with CD4+ counts of < 200 cells/microl
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Initiation of ART in most patients with CD4+ counts of 200‐350 cells/microl
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Delay of therapy in patients with CD4+ counts of > 350 cells/microl
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adherence to therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Genotype studies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Individualized approach to therapy
Number of subjects: 0
Study: 15677775

Group type: EXPERIMENTAL
Intervention: glargine plus OAD
Number of subjects: 371

Group type: COMPARATOR
Intervention: 70/30
Number of subjects: 371
Study: 11517136

Group type: EXPERIMENTAL
Intervention: Synchronized Intermittent Mandatory Ventilation (SIMV)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Biphasic Positive Airway Pressure (BIPAP)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (volume-controlled mechanical ventilation)
Number of subjects: 10
Study: 9491833

Group type: EXPERIMENTAL
Intervention: Continuous transdermal oestradiol (50 microg daily)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Transdermal oestradiol (50 microg daily) and medroxyprogesterone acetate (10 mg daily for the first 12 days of each month)
Number of subjects: 62
Study: 7942414

Group type: EXPERIMENTAL
Intervention: Beta blockers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Anticoagulant drugs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Antiarrhythmic drugs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Direct-current cardioversion
Number of subjects: 0
Study: 2906118

Group type: EXPERIMENTAL
Intervention: CHOP regimen
Number of subjects: 199

Group type: COMPARATOR
Intervention: Chlorambucil plus prednisone
Number of subjects: 199
Study: 2066755

Group type: EXPERIMENTAL
Intervention: cyclophosphamide-doxorubicin
Number of subjects: 298

Group type: EXPERIMENTAL
Intervention: cisplatin-teniposide and cyclophosphamide-doxorubicin
Number of subjects: 298

Group type: EXPERIMENTAL
Intervention: N-myc gene amplification
Number of subjects: 298

Group type: EXPERIMENTAL
Intervention: tumor cell ploidy and N-myc gene copy number
Number of subjects: 298
Study: 794661

Group type: EXPERIMENTAL
Intervention: Salbutamol (100 mug)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Aminophylline (250 mg)
Number of subjects: 23
Study: 31597907

Group type: EXPERIMENTAL
Intervention: Rhythm control strategy
Number of subjects: 2513

Group type: COMPARATOR
Intervention: Rate control strategy
Number of subjects: 2513
Study: 31989155

Group type: EXPERIMENTAL
Intervention: High-dose DCB (In.Pact™)
Number of subjects: 414

Group type: COMPARATOR
Intervention: Low-dose DCB (Ranger™)
Number of subjects: 414
Study: 31043185

Group type: EXPERIMENTAL
Intervention: Combat Stress Inoculation (CSI) group
Number of subjects: 305

Group type: COMPARATOR
Intervention: Control group (standard educational program)
Number of subjects: 305

Group type: EXPERIMENTAL
Intervention: Both groups (CSI and Control)
Number of subjects: 305
Study: 28835366

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 245
Study: 25640628

Group type: EXPERIMENTAL
Intervention: RT plus standard-dose cisplatin and 5-fluorouracil (SDPF) chemotherapy (arm A)
Number of subjects: 142

Group type: COMPARATOR
Intervention: RT plus low-dose cisplatin and 5-fluorouracil (LDPF) chemotherapy (arm B)
Number of subjects: 142
Study: 23642047

Group type: COMPARATOR
Intervention: Oxygen saturation target of 85 to 89%
Number of subjects: 2448
Study: 22009765

Group type: EXPERIMENTAL
Intervention: Tissue electrical properties measurements using tiny surface electrodes in four-electrode configuration
Number of subjects: 15
Study: 20108073

Group type: EXPERIMENTAL
Intervention: Hypocaloric low-glycemic index diet
Number of subjects: 26

Group type: COMPARATOR
Intervention: Hypocaloric high-glycemic index diet
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Both groups combined
Number of subjects: 26
Study: 16881990

Group type: EXPERIMENTAL
Intervention: Water aerobics
Number of subjects: 390

Group type: COMPARATOR
Intervention: Land-based physical exercise program
Number of subjects: 390
Study: 15956927

Group type: EXPERIMENTAL
Intervention: Adenosine (Ado) infusion over 10 min at systemic pressure during IAC bypass surgery
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo infusion over 10 min at systemic pressure during IAC bypass surgery
Number of subjects: 34
Study: 11172846

Group type: EXPERIMENTAL
Intervention: 0.3 mg esterified estrogen
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: 0.625 mg conjugated equine estrogen
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study: 9644978

Group type: EXPERIMENTAL
Intervention: Doxazosin 4-8 mg (mean 5.7 mg)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study: 7880945

Group type: EXPERIMENTAL
Intervention: Light therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Seasonal variation
Number of subjects: 0
Study: 3264528

Group type: EXPERIMENTAL
Intervention: 10 mg ketorolac
Number of subjects: 32

Group type: COMPARATOR
Intervention: 50 mg pethidine
Number of subjects: 32

Group type: COMPARATOR
Intervention: 100 mg pethidine
Number of subjects: 32
Study: 29316888

Group type: EXPERIMENTAL
Intervention: Sensorimotor training (SMT)
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Whole body vibration (WBV)
Number of subjects: 236

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 236
Study: 27856335

Group type: EXPERIMENTAL
Intervention: Active grape formulation
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (formulation free of polyphenols)
Number of subjects: 10
Study: 26032843

Group type: EXPERIMENTAL
Intervention: Continued pharmacist intervention for another 24 months
Number of subjects: 54

Group type: COMPARATOR
Intervention: One-time educational materials (control group)
Number of subjects: 54
Study: 23496848

Group type: EXPERIMENTAL
Intervention: Advice to consume low‐mercury/high‐DHA fish (n=18)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Advice + grocery store gift cards (GC) to purchase fish (n=17)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control messages (n=20)
Number of subjects: 61
Study: 21594208

Group type: EXPERIMENTAL
Intervention: Scaling and root planing followed by local application of 10% doxycycline hyclate (SRP-D)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Scaling and root planing (SRP)
Number of subjects: 45
Study: 19012973

Group type: EXPERIMENTAL
Intervention: Auditory processing problem checklist (parental report)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Auditory processing problems
Number of subjects: 104
Study: 17122241

Group type: EXPERIMENTAL
Intervention: Single-injection technique (Group S) with 25 mL of mepivacaine 1%
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Double-injection technique (Group D) with 12.5 mL of mepivacaine 1% injected twice
Number of subjects: 60

Group type: COMPARATOR
Intervention: Superficial peroneal nerve block (Group S)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Superficial peroneal nerve block (Group D)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Tibial nerve block (Group D)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Paresthesias during block procedure
Number of subjects: 60